Neeta Pandit-Taskar

9PUBLICATIONS
88CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersHaematological tumoursInstruments and techniques
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 07, 2025
ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial Results.

Emily K Slotkin, Audrey Mauguen, Filemon S Dela Cruz

|Jul 31, 2024
Feasibility of safe outpatient treatment in pediatric patients following intraventricular radioimmunotherapy with 131I-omburtamab for leptomeningeal disease.

Kavya Prasad, Brian E Serencsits, Bae P Chu

|Mar 11, 2024
Feasibility of safe outpatient treatment in pediatric patients following intraventricular radioimmunotherapy with 131I-omburtamab for leptomeningeal disease.

Kavya Prasad, Brian E Serencsits, Bae P Chu

|Jul 05, 2023
Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer.

Steven B Maron, Walid Chatila, Henry Walch

|Sep 17, 2022
Imaging recommendations in pediatric lymphoma: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper.

Joyce Mhlanga, Adina Alazraki, Steve Y Cho

|Mar 05, 2022
Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab.

Todd L Rosenblat, Michael R McDevitt, Jorge A Carrasquillo

Pageof 2

Frequent Collaborators

2 joint publications

Jason S Lewis

2 joint publications

Jorge A Carrasquillo

2 joint publications

Steven M Larson

1 joint publications

Kelly E Henry